AGE-RAGE Axis Involvement in Allergies and Autoimmunity: Cellular Signaling, Barrier Dysfunction and Immune...

Area of Science:

• Immunology
• Biochemistry
• Pathophysiology

Background:

• Advanced glycation end-products (AGEs) are implicated in inflammatory processes.
• AGEs, along with other ligands, bind to the receptor for advanced glycation end-products (RAGE).
• This binding activates pro-inflammatory signaling pathways and cytokine release.

Purpose of the Study:

• To review the role of the AGE-RAGE axis in allergic and autoimmune diseases.
• To highlight the immunopathogenesis of these conditions involving the AGE-RAGE pathway.
• To explore potential diagnostic and therapeutic strategies targeting the AGE-RAGE axis.

Main Methods:

• Literature review of studies on the AGE-RAGE axis.
• Analysis of the role of AGEs and RAGE in various allergic conditions (asthma, atopic dermatitis, food allergies).
• Examination of the AGE-RAGE axis in autoimmune diseases (rheumatoid arthritis, lupus erythematosus, Hashimoto's thyroiditis).

Main Results:

• The AGE-RAGE axis is significantly involved in the immunopathogenesis of both allergic and autoimmune diseases.
• Evidence demonstrates the role of AGE-RAGE in conditions like bronchial asthma, atopic dermatitis, rheumatoid arthritis, and lupus erythematosus.
• The pathway's involvement is crucial for understanding disease mechanisms.

Conclusions:

• The AGE-RAGE axis is a key player in the development and progression of allergic and autoimmune diseases.
• Targeting the AGE-RAGE pathway presents promising avenues for novel diagnostic markers and therapeutic interventions.
• Further extensive research is required to fully elucidate this pathway and translate findings into clinical practice.